SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 799.64-0.2%12:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (97)5/13/1997 8:08:00 PM
From: Miljenko Zuanic   of 3559
 
Richard,

It is a real beauty. Finally, after few hard research years the recognition come. There are loot of work to be done, and accounting regn scientific and R&D expertise, the future results will pay for efforts. Can you imagine (my dream) what will be today price if they have little luck with BDNF!! I was patient (mad on amgn, yes, and still I am), but now I will be even more patients with regn. Their future is for real!

They still have BDNF, NT-3, CNTF, Oxokine, and Cytokine, Merck, manufacturing. Few things will bring revenue and finance for future clinicals.

CL, should we send letter of ours condolence to amgn!

mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext